Assessing heterogeneity in surrogacy using censored data

DOI10.1002/sim.10122zbMATH Open1545.6249MaRDI QIDQ6618309

Layla Parast, L. Tian, Tianxi Cai

Publication date: 14 October 2024

Published in: Statistics in Medicine (Search for Journal in Brave)

zbMATH Keywords

survivalnonparametrictreatment effectbiomarker

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cites Work

• Unnamed Item
• Uniform consistency of the kernel conditional Kaplan-Meier estimate
• Surrogate Measures and Consistent Surrogates
• Evaluating Candidate Principal Surrogate Endpoints
• Calibrating parametric subject-specific risk estimation
• Criteria for the Validation of Surrogate Endpoints in Randomized Experiments
• Using a surrogate marker for early testing of a treatment effect
• Model-free approach to quantifying the proportion of treatment effect explained by a surrogate marker
• Patterns of treatment effects in subsets of patients in clinical trials
• Solutions for Surrogacy Validation with Longitudinal Outcomes for a Gene Therapy
• Testing for Heterogeneity in the Utility of a Surrogate Marker
• Bayesian hierarchical meta-analytic methods for modeling surrogate relationships that vary across treatment classes using aggregate data
• Incorporating baseline covariates to validate surrogate endpoints with a constant biomarker under control arm
• Using a surrogate with heterogeneous utility to test for a treatment effect

This page was built for publication: Assessing heterogeneity in surrogacy using censored data